CIC
protein-codingcapicua transcriptional repressor
Gene summary
The protein encoded by this gene is an ortholog of the Drosophila melanogaster capicua gene, and is a member of the high mobility group (HMG)-box superfamily of transcriptional repressors. This protein contains a conserved HMG domain that is involved in DNA binding and nuclear localization, and a conserved C-terminus. Studies suggest that the N-terminal region of this protein interacts with Atxn1 (GeneID:6310), to form a transcription repressor complex, and in vitro studies suggest that polyglutamine-expansion of ATXN1 may alter the repressor activity of this complex. Mutations in this gene have been associated with olidogdendrogliomas (PMID:21817013). In addition, translocation events resulting in gene fusions of this gene with both DUX4 (GeneID:100288687) and FOXO4 (GeneID:4303) have been associated with round cell sarcomas. There are multiple pseudogenes of this gene found on chromosomes 1, 4, 6, 7, 16, 20, and the Y chromosome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~27.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0030910
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0030910
Submitter: Illumina
Inheritance Pattern: AD
Disease ID:MONDO:0015802
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0030910
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0100034
Submitter: Franklin by Genoox
In a trio-based genetic analysis on patients with CFD and identified de-novo mutation in CIC. additioanly in a cohort of 48 CFD cases, 3 patients carried deleterious variants IN CIC http://dx.doi.org/10.1136/jmedgenet-2020-106987
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: ClinGen
*CIC* encodes capicua, a transcriptional repressor that plays a role in the development of the central nervous system. *CIC* was first reported in relation to autosomal dominant complex neurodevelopmental disorder in 2017 (Lu et al., PMID: 28288114). The clinical features of affected individuals are variable and include developmental delay, intellectual disability, autism or autistic features, seizures and brain MRI abnormalities. Eight variants (4 frameshift, 2 nonsense, and 2 missense) that have been reported in eight probands in four publications (PMIDs: 21076407, 24307393, 28288114, 35165976) are included in this curation. Most variants are *de novo*. Two affected siblings likely inherited the variant from a parent with germline mosaicism, and in another proband the variant was inherited from an unaffected parent with low level mosaicism (PMID: 28288114). More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. *CIC* is highly constrained for truncating variants but not for missense variants (gnomAD v2.1.1). The mechanism of pathogenicity is loss of function. This gene-disease relationship is also supported by experimental evidence, including conditional mouse models (PMID: 28288114) and functional alterations in patient and non-patient cells (PMIDs: 32820034, 35165976). CIC binds to the promoter of folate transport genes, including *FOLR1*; loss-of-function variants in *CIC* downregulate FOLR1 expression, leading to cerebral folate deficiency (PMID: 32820034). In summary, there is definitive evidence supporting the relationship between *CIC* and autosomal dominant complex neurodevelopmental disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on January 18, 2023 (SOP Version 9).
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CIC variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001386298.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 14 | 202 | 2 | 219 | |
| missense | 1 | 12 | 547 | 138 | 3 | 701 |
| nonsense | 6 | 11 | 11 | 1 | 29 | |
| start loss | 0 | |||||
| frameshift | 25 | 34 | 17 | 76 | ||
| splice donor/acceptor (+/-2bp) | 2 | 5 | 13 | 20 | ||
| Total | 34 | 63 | 602 | 341 | 5 | 1045 |
Highest pathogenic variant AF is 0.00000821145
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001373227.1 | 20 | MANE Select | |
| Ensembl | ENSP00000505728.1 | 20 | MANE Select | |
| RefSeq | NP_001291744.1 | 20 | Standard | |
| RefSeq | NP_001366409.1 | 20 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| cicb | Danio rerio | Structure: primitive erythrocyte differentiation Quality: increased occurrence abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- negative regulation of transcription by RNA polymerase II
- brain development
- learning
- memory
- social behavior
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA binding
- chromatin binding
- protein binding
Cellular Component
- nucleus
- nucleoplasm
- protein-containing complex
- intracellular membrane-bounded organelle
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000575354
- Coding exons
- 20
- Length
- 27261
- Individuals with no LoFs
- 125739
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 9
- Defined
- 125748
- p
- 0.0000358
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.726 | 904 | 968 | 0.934 | 0.0000644 | 9995 |
| Missense (PolyPhen) | 305 | 422.99 | 0.72107 | 4198 | ||
| Synonymous | -4.48 | 545 | 427 | 1.28 | 0.0000297 | 3758 |
| Loss of Function | 6.02 | 4 | 49.9 | 0.0801 | 0.00000259 | 602 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000055 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000036 | 0.000035 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcriptional repressor which plays a role in development of the central nervous system (CNS). In concert with ATXN1 and ATXN1L, involved in brain development. {ECO:0000250|UniProtKB:Q924A2}.;
Recessive Scores
- pRec
- 0.176
Intolerance Scores
- LoFtool
- 0.0161
- RVIS EVS
- -3.38
- RVIS percentile EVS
- 0.38
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.757
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |